Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-29,870
Closed -$1.28M 73
2021
Q3
$1.28M Sell
29,870
-29,755
-50% -$1.32M 1.37% 31
2021
Q2
$2.33M Buy
59,625
+625
+1% +$24.3K 2.33% 16
2021
Q1
$2.14M Buy
+59,000
New +$2.09M 2.37% 14
2015
Q4
Sell
-224,369
Closed -$6.69M 43
2015
Q3
$6.69M Sell
224,369
-14,227
-6% -$456K 5.32% 2
2015
Q2
$7.59M Sell
238,596
-20,354
-8% -$663K 5.21% 2
2015
Q1
$8.55M Sell
258,950
-9,546
-4% -$303K 5.62% 1
2014
Q4
$7.93M Sell
268,496
-28,057
-9% -$804K 5.02% 3
2014
Q3
$8.32M Sell
296,553
-8,780
-3% -$246K 4.84% 1
2014
Q2
$8.6M Buy
305,333
+4,112
+1% +$117K 4.36% 3
2014
Q1
$9.18M Sell
301,221
-5,052
-2% -$151K 4.98% 1
2013
Q4
$8.9M Sell
306,273
-6,048
-2% -$176K 4.84% 3
2013
Q3
$8.51M Buy
312,321
+5,007
+2% +$136K 4.94% 3
2013
Q2
$8.17M Buy
+307,314
New +$8.49M 4.71% 2

Other funds holding PFE

Lesa Sroufe & Co's PFE Position: Q4 2021 in Review

Lesa Sroufe & Co sold out of Pfizer (PFE) in Q4 2021, closing a stake of 29,870 shares — an estimated $1.28M sold.

Lesa Sroufe & Co first reported a position in PFE in Q2 2013 and held it in 13 quarters. The position peaked at $9.18M in Q1 2014. 3,263 funds tracked by Wall St. Rank hold PFE as of Q4 2021.

  • Lesa Sroufe & Co reported no remaining Pfizer position as of Q4 2021 after selling out during the quarter.
  • Lesa Sroufe & Co sold 29,870 Pfizer shares in Q4 2021, an estimated $1.28M.
  • Lesa Sroufe & Co first reported a position in Pfizer in Q2 2013 and held it in 13 quarters.
  • Lesa Sroufe & Co's Pfizer position peaked at $9.18M in Q1 2014.
  • 3,263 funds tracked by Wall St. Rank held Pfizer as of Q4 2021.

Based on Lesa Sroufe & Co's 13F filing for Q4 2021, filed 28 Jan 2022.